Heather Kompart contributes to innovations for health evaluations and our work on polygenic risks scores as a Policy Analyst in the Science team. She has an MPhil in Genomic Medicine from the University of Cambridge and. and a BSc in Medical Science (Human Genomics) from the University of Exeter.
Heather previously worked in the NHS supporting patient reporting from the 100,000 Genomes Project. In addition to policy work Heather has an interest in increasing community engagement and awareness of rare disease.
Key skills are:
- Technology assessment
- Genomic healthcare integration
- Clinical pathway implementation
- Infectious disease genomics
- Addressing sepsis requires speedy solutions: enter rapid diagnostics
- Rethinking sepsis: why research should pivot to early diagnosis
- Building the case for polygenic scores: what is the evidence for cost-effectiveness?
- Delivering diagnosis for prenatal medicine – lessons from implementation of a national service
- Metagenomic sequencing in public health – can long read sequencing be used to tackle antimicrobial resistance?
- Gene therapies and AI – is this the next phase of genomic medicine?
- Rapid metagenomics looks promising to reduce AMR and sepsis in ICU
- Host genomics beyond the pandemic
- Host genomics and COVID-19: where are we now?
- Babb de Villiers C, Plans-Beriso E, Erady C, Blackburn L, Wilson H, Turner H, Kuhn I, Barahona-López C, Diez-Echave P, Hernández OR, et al. Biomarkers for Personalised Primary or Secondary Prevention in Cardiovascular Diseases: A Rapid Scoping Review. International Journal of Molecular Sciences. 2025; 26(19):9346.
- Biomarkers for personalised prevention of chronic diseases: a common protocol for three rapid scoping reviews. Syst Rev 13, 147 (2024). Plans-Beriso, E., Babb de Villiers, C., Petrova, D. Turner, H., Blackburn, L. et al. https://doi.org/10.1186/
s13643-024-02554-9
